All Stories

  1. Efficacy of ultra-low-dose (0.1 mg) ranibizumab intravitreal injection for treatment of prethreshold type 1 retinopathy of prematurity: A case series
  2. Evaluation of the treatment of retinopathy of prematurity in preterm infants in Alexandria University Hospital
  3. Risk factors contributing to the development of retinopathy of prematurity in Egyptian infants.